A team of scientists was able to characterize a new genetic immunodeficiency resulting from a mutation in a gene named STAT2. This mutation causes patients to be extremely vulnerable to normally mild childhood illnesses such as rotavirus and enterovirus. The comprehensive analysis of the genetic defect allows clinicians to provide children with the proper therapies before illnesses prove fatal.